Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
CA
CAF.PA
CA
CAF.PA
CAF.PA
News
·
Jungfraubahn Holding (SWX:JFN) Stock Looks About Right On Earnings Today
Mkt Cap
N/A
Volume
1.27K
Next Earnings
N/A
Chart
Earnings
News
About
Dividends
Insider
Filings
Jungfraubahn Holding (SWX:JFN) Stock Looks About Right On Earnings Today
Jungfraubahn Holding has rewarded long term holders with a strong multi year share price run, which now puts the focus squarely on what investors are paying for its earnings. With the stock recently closing at CHF 232.0, the key issue is whether that price is well grounded in the…
finance.yahoo.com · Oct 17, 2026
Is Billerud (OM:BILL) Undervalued Or Are Its Sales Priced Right?
Billerud comes to the market today with a mixed share price record, and the live question is whether the current valuation really lines up with what its sales can support. Recent moves give investors some fresh data points, but the link between the stock price and the revenue bas…
finance.yahoo.com · Oct 17, 2026
Novartis Scraps Another Drug Study. Why the Stock Is Holding Steady.
Novartis shelves a study for Fabhalta in patients with a serious kidney-disease complication, adding to a growing list of clinical setbacks. Continue Reading
finance.yahoo.com · Oct 16, 2026
Novartis' Loss of Exclusivity Continued to Erode Entresto Sales in Q3, RBC Says
Novartis' (NVS) loss of exclusivity on its Entresto heart failure medication last year continued to PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subsc…
finance.yahoo.com · Oct 16, 2026
Studsvik signs landmark agreement to manage Norway's legacy spent nuclear fuel
The frame agreement with Norwegian Nuclear Decommissioning (NND) runs until 2055, has an estimated contractual minimum value of about SEK 875 million and an estimated total value for Studsvik of SEK 3-4 billion, and covers transport, treatment to meet long-term storage requiremen…
finance.yahoo.com · Oct 16, 2026
Is Hera (BIT:HER) Reasonably Priced After A 54% Three Year Gain?
Hera has delivered a solid 53.6% share price gain over the past three years, which naturally puts fresh attention on whether that move is backed up by its earnings power today. With the stock last closing at €3.52, the question now is how much of the business's profit profile is …
finance.yahoo.com · Oct 16, 2026
3 AI Stocks With Revenue Growth Up To 29%
Fresh CPI data shows US inflation at 3.7% in September, with AI data center construction flagged as one of the cost drivers. Rising prices and the prospect of higher rates are pressuring many growth stories, while the businesses supplying the physical plumbing of AI are tied to r…
finance.yahoo.com · Oct 14, 2026
Gecina – Business at September 30, 2026
Sustained Leasing Momentum Confirmed PARIS, October 14, 2026--(BUSINESS WIRE)--Regulatory News: Gecina (Paris:GFC): | Key takeaways Leasing accelerates: 140,000 sq.m of renewals and relettings in nine months, including 92,000 sq.m in Q3 alone. Tenants keep choosing the most centr…
finance.yahoo.com · Oct 14, 2026
MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies
Senior appointments from Pfizer, Novartis, Arbor Biotechnologies, and Orum Therapeutics bring preclinical development, structural biology, and portfolio strategy depth as MindWalk prepares its programs for preclinical efficacy studies BOSTON, October 14, 2026--(BUSINESS WIRE)--Mi…
finance.yahoo.com · Oct 14, 2026
What Is Novartis (SWX:NOVN) Signaling With Its Dual Hives Approval And MS Data?
Novartis (SWX:NOVN) received FDA approval for Rhapsido (remibrutinib) as a treatment for chronic spontaneous urticaria and symptomatic dermographism when antihistamines are insufficient. Rhapsido becomes the first therapy in the US with a dual indication in chronic hives that cov…
finance.yahoo.com · Oct 14, 2026
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
CA
CAF.PA
CAF.PA
Buy
Sell
Market
Limit
Soon
CAF.PA
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any CAF.PA yet.
Related Tickers
Earnings
Dividends
Last · May 4
Amount
$2.59
Yield
3.02%
Annual
$2.59